Literature DB >> 27717434

Emerging Systemic Therapies for the Management of Penile Cancer.

Shilpa Gupta1, Guru Sonpavde2.   

Abstract

Penile squamous cell carcinoma (PSCC) is a rare cancer, but is more common in developing countries. Locally advanced and metastatic PSCC is associated with significant morbidity and mortality, with the prognosis remaining extremely poor. The authors searched PubMed and published abstracts for metastatic PSCC studies to describe emerging therapies. Multimodality treatment using chemotherapy, radiation, and consolidative surgery are standard of care. Utilizing anti-EGFR therapies and novel immunotheraputic approaches may help improve outcomes in PSCC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Combined modality therapy; EGFR; PD-1; Penile squamous cell carcinoma; Targeted therapy; VEGF

Mesh:

Year:  2016        PMID: 27717434     DOI: 10.1016/j.ucl.2016.06.009

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  18F-FDG PET/CT as a prognostic factor in penile cancer.

Authors:  André Salazar; Eduardo Paulino Júnior; Paulo Guilherme O Salles; Raul Silva-Filho; Edna A Reis; Marcelo Mamede
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-24       Impact factor: 9.236

2.  High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.

Authors:  Jiayi Zhang; Rong Cong; Kai Zhao; Yi Wang; Ninghong Song; Min Gu
Journal:  Ann Transl Med       Date:  2019-07

Review 3.  Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.

Authors:  Juan Chipollini; Sharon Chaing; Mounsif Azizi; Laura C Kidd; Patricia Kim; Philippe E Spiess
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

4.  The Biomarker Potential of Caveolin-1 in Penile Cancer.

Authors:  Andrej Panic; Henning Reis; Alina Wittka; Christopher Darr; Boris Hadaschik; Verena Jendrossek; Diana Klein
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

5.  miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma.

Authors:  Xingliang Tan; Zhenhua Liu; Yanjun Wang; Zhiming Wu; Yuantao Zou; Sihao Luo; Yi Tang; Dong Chen; Gangjun Yuan; Kai Yao
Journal:  Cell Death Dis       Date:  2022-09-23       Impact factor: 9.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.